Related Experiment Video
Updated: Jul 31, 2025
09:08
Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
Published on: October 14, 2021
5.6K
Cutaneous Lupus Erythematosus: An Update on Pathogenesis and Future Therapeutic Directions
Dennis Niebel1, Luka de Vos2, Tanja Fetter2
1Department of Dermatology, University Hospital Regensburg, 93053, Regensburg, Germany.
American Journal of Clinical Dermatology
|May 4, 2023
Summary
Cutaneous lupus erythematosus (CLE) treatment is evolving. Identifying specific inflammatory signatures in skin lesions may predict responses to targeted therapies like T-cell, B-cell, or interferon-directed treatments.
Area of Science:
- Dermatology
- Immunology
- Autoimmune Diseases
Background:
- Lupus erythematosus encompasses systemic lupus erythematosus (SLE) and cutaneous lupus erythematosus (CLE), affecting various organs or skin only.
- CLE pathogenesis involves keratinocytes, T cells, and plasmacytoid dendritic cells (pDCs), triggered by UV light, smoking, or drugs.
- Current CLE treatments include trigger avoidance, UV protection, topical therapies, and broad immunosuppressants, with limited targeted options.
Purpose of the Study:
- To explore the potential of targeted therapies for cutaneous lupus erythematosus (CLE) management.
- To investigate if specific inflammatory profiles in CLE lesions can predict response to novel treatments.
- To highlight the need for personalized therapeutic strategies in refractory CLE.
Main Methods:
- Review of current understanding of CLE pathogenesis and treatment landscape.
- Speculation on predicting therapeutic response based on inflammatory signatures (T cells, B cells, pDCs, type I IFN).
- Proposal for pretherapeutic histological assessment to stratify patients for targeted therapies.
Main Results:
- Heterogeneity in CLE suggests individual variables influence disease presentation and treatment response.
- Specific inflammatory signatures (T cells, B cells, pDCs, type I IFN) may predict efficacy of targeted therapies.
- Emerging targeted therapies for SLE offer new perspectives for CLE management.
Conclusions:
- Pretherapeutic histological analysis of inflammatory infiltrates can guide patient stratification for targeted therapies.
- T-cell, B-cell, pDC, and IFN-directed therapies show promise for refractory CLE.
- Janus kinase (JAK) and spleen tyrosine kinase (SYK) inhibitors may offer future treatment options, emphasizing interdisciplinary care.
Related Concept Videos
01:23Skin Diseases and Disorders
4.0K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
4.0K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
01:22iPS Cell Differentiation
2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K
01:29Microorganisms in Medicine and Therapeutics
86
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
86